Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled trial of Xipayi Guyin Ye for prevention of radiation-induced oral mucositis
CTR20255115Phase 2Active
- Sponsor
- Xinqikang Pharmaceutical
- Start
- Dec 2025
- Countries
- 1
01
Overview
A Phase 2 trial of Xipayi Guyin Ye in stomatitis, sponsored by Xinqikang Pharmaceutical. Started Dec 2025; status: active.
02
Drugs
Xipayi Guyin Ye
03
Conditions
stomatitis
Beyond the preview
Go deeper on CTR20255115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20255115.